TITLE

Neurotrophin Gene Therapy in Deafened Ears with Cochlear Implants: Long-term Effects on Nerve Survival and Functional Measures

AUTHOR(S)
Pfingst, Bryan; Colesa, Deborah; Swiderski, Donald; Hughes, Aaron; Strahl, Stefan; Sinan, Moaz; Raphael, Yehoash; Pfingst, Bryan E; Colesa, Deborah J; Swiderski, Donald L; Hughes, Aaron P; Strahl, Stefan B
PUB. DATE
December 2017
SOURCE
JARO - Journal of the Association for Research in Otolaryngology;Dec2017, Vol. 18 Issue 6, p731
SOURCE TYPE
Academic Journal
DOC. TYPE
journal article
ABSTRACT
Because cochlear implants function by stimulating the auditory nerve, it is assumed that the condition of the nerve plays an important role in the efficacy of the prosthesis. Thus, considerable research has been devoted to methods of preserving the nerve following deafness. Neurotrophins have been identified as a potential contributor to neural health, but most of the research to date has been done in young animals and for short periods (less than 3 to 6 months) after the onset of treatment. The first objective of the current experiment was to examine the effects of a neurotrophin gene therapy delivery method on spiral ganglion neuron (SGN) preservation and function in the long term (5 to 14 months) in mature guinea pigs with cochlear implants. The second objective was to examine several potential non-invasive monitors of auditory nerve health following the neurotrophin gene therapy procedure. Eighteen mature adult male guinea pigs were deafened by cochlear perfusion of neomycin and then one ear was inoculated with an adeno-associated viral vector with an Nft3-gene insert (AAV.Ntf3) and implanted with a cochlear implant electrode array. Five control animals were deafened and inoculated with an empty AAV and implanted. Data from 43 other guinea pig ears from this and previous experiments were used for comparison: 24 animals implanted in a hearing ear, nine animals deafened and implanted with no inoculation, and ten normal-hearing non-implanted ears. After 4 to 21 months of psychophysical and electrophysiological testing, the animals were prepared for histological examination of SGN densities and inner hair cell (IHC) survival. Seventy-eight percent of the ears deafened and inoculated with AAV.Ntf3 showed better SGN survival than the 14 deafened-control ears. The degree of SGN preservation following the gene therapy procedure was variable across animals and across cochlear turns. Slopes of psychophysical multipulse integration (MPI) functions were predictive of SGN density, but only in animals with preserved IHCs. MPI was not affected by the AAV.Ntf3 treatment, but there was a minor improvement in temporal integration (TI). AAV.Ntf3 treatment had significant effects on ECAP and EABR amplitude growth func-tion (AGF) slopes; the reduction in slope in deafened ears was ameliorated by the AAV.Ntf3 treatment. Slopes of the ECAP and EABR AGFs were predictive of SGN density in a broad area near and just apical to the implant. The highest ensemble spontaneous activity (ESA) values were seen in animals with surviving IHCs, but AAV.Ntf3 treatment in deafened ears resulted in slightly higher ESA values compared to deafened untreated ears. Overall, a combination of the psychophysical and electrophysiological measures can be useful for monitoring the health of the implanted cochlea in guinea pigs. These measures should be applicable for assessing cochlear health in human subjects.
ACCESSION #
126245731

 

Related Articles

  • Viability of Long-Term Gene Therapy in the Cochlea. Atkinson, Patrick J.; Wise, Andrew K.; Flynn, Brianna O.; Nayagam, Bryony A.; Richardson, Rachael T. // Scientific Reports;4/25/2014, p1 

    Gene therapy has been investigated as a way to introduce a variety of genes to treat neurological disorders. An important clinical consideration is its long-term effectiveness. This research aims to study the long-term expression and effectiveness of gene therapy in promoting spiral ganglion...

  • Neurotrophin Gene Therapy for Sustained Neural Preservation after Deafness. Atkinson, Patrick J.; Wise, Andrew K.; Flynn, Brianna O.; Nayagam, Bryony A.; Hume, Clifford R.; O'Leary, Stephen J.; Shepherd, Robert K.; Richardson, Rachael T. // PLoS ONE;Dec2012, Vol. 7 Issue 12, p1 

    The cochlear implant provides auditory cues to profoundly deaf patients by electrically stimulating the residual spiral ganglion neurons. These neurons, however, undergo progressive degeneration after hearing loss, marked initially by peripheral fibre retraction and ultimately culminating in...

  • Enhanced Survival of Spiral Ganglion Cells After Cessation of Treatment with Brain-Derived Neurotrophic Factor in Deafened Guinea Pigs. Agterberg, Martijn; Versnel, Huib; Dijk, Lotte; Groot, John; Klis, Sjaak // JARO - Journal of the Association for Research in Otolaryngology;Sep2009, Vol. 10 Issue 3, p355 

    Exogenous delivery of neurotrophic factors into the cochlea of deafened animals rescues spiral ganglion cells (SGCs) from degeneration. To be clinically relevant for human cochlear implant candidates, the protective effect of neurotrophins should persist after cessation of treatment and the...

  • Effects of Brain-Derived Neurotrophic Factor (BDNF) and Electrical Stimulation on Survival and Function of Cochlear Spiral Ganglion Neurons in Deafened, Developing Cats. Leake, Patricia; Stakhovskaya, Olga; Hetherington, Alexander; Rebscher, Stephen; Bonham, Ben // JARO - Journal of the Association for Research in Otolaryngology;Apr2013, Vol. 14 Issue 2, p187 

    Both neurotrophic support and neural activity are required for normal postnatal development and survival of cochlear spiral ganglion (SG) neurons. Previous studies in neonatally deafened cats demonstrated that electrical stimulation (ES) from a cochlear implant can promote improved SG survival...

  • Effects of Localized Neurotrophin Gene Expression on Spiral Ganglion Neuron Resprouting in the Deafened Cochlea. Wise, Andrew K.; Hume, Clifford R.; Flynn, Brianna O.; Jeelall, Yogesh S.; Suhr, Courtney L.; Sgro, Beatrice E.; O'Leary, Stephen J.; Shepherd, Robert K.; Richardson, Rachael T. // Molecular Therapy;Jun2010, Vol. 18 Issue 6, p1111 

    A cochlear implant may be used to electrically stimulate spiral ganglion neurons (SGNs) in people with severe sensorineural hearing loss (SNHL). However, these neurons progressively degenerate after SNHL due to loss of neurotrophins normally supplied by sensory hair cells (HCs). Experimentally,...

  • Improved Auditory Nerve Survival with Nanoengineered Supraparticles for Neurotrophin Delivery into the Deafened Cochlea. Wise, Andrew K.; Tan, Justin; Wang, Yajun; Caruso, Frank; Shepherd, Robert K. // PLoS ONE;10/27/2016, Vol. 11 Issue 10, p1 

    Cochlear implants electrically stimulate spiral ganglion neurons (SGNs) in order to provide speech cues to severe-profoundly deaf patients. In normal hearing cochleae the SGNs depend on endogenous neurotrophins secreted by sensory cells in the organ of Corti for survival. SGNs gradually...

  • How to regrow lost hearing.  // New Scientist;9/18/2004, Vol. 183 Issue 2465, p13 

    This article reports that a technique that stimulates auditory nerve cell endings to resprout could allow more people to recover lost hearing. In some cases of deafness, cochlear implants can restore hearing by bypassing damaged hair cells and directly stimulating the auditory nerve. But the...

  • What does a cochlear implant do to your brain? Plastic changes in the primary auditory cortex with long-term deafness and cochlear implant use. Fallon, J. B. // Proceedings of the Physiological Society;2013, p142P 

    Sensorineural hearing loss initiates a cascade of anatomical and functional changes within the auditory system. The secondary loss of spiral ganglion neurones, the target cells of cochlear implants, is the most critical peripheral change; and there are a range of atrophic changes within the...

  • Benefits of Cochlear Implantation in Early-Deafened Adults: The Toronto Experience. Chee, Gerard H.; Goldring, Jennifer E.; Shipp, David B.; Ng, Amy H.C.; Chen, Joseph M.; Nedzelski, Julian M. // Journal of Otolaryngology;Jan/Feb2004, Vol. 33 Issue 1, p26 

    Objective: To present the results of a survey administered to a group of early-deafened cochlear implants adults and to report the level of perceived benefit. Design: Prospective Setting: Large tertiary referral centre. Method: A 47-item questionnaire designed to evaluate cochlear implant use...

  • Enhanced Auditory Neuron Survival Following Cell-Based BDNF Treatment in the Deaf Guinea Pig. Pettingill, Lisa N.; Wise, Andrew K.; Geaney, Marilyn S.; Shepherd, Robert K. // PLoS ONE;2011, Vol. 6 Issue 4, p1 

    Exogenous neurotrophin delivery to the deaf cochlea can prevent deafness-induced auditory neuron degeneration, however, we have previously reported that these survival effects are rapidly lost if the treatment stops. In addition, there are concerns that current experimental techniques are not...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics